ASX 200 ends at near 2-month high
ASX 200's intraday high 8 pts shy of record
Banks end as top gainers, for record closing high
Miners, oil firms track commodity prices higher
Australian shares jumped on Thursday to within touching distance of their all-time high, tracking the record-breaking run on Wall Street.
The S&P/ASX 200 benchmark index (xjo) rose 0.9% to close at 7,889.6 points, a near two-month high.
It hit a session-high of 7,902.6, just eight points shy of its all-time high.
Globally, stocks rose, with markets from Tokyo to New York at record highs, while traders counted down to U.S. data that is expected to show inflation easing and pave the way for rate cuts in September.
"Aussie equities are riding on a string of historical winning waves from Wall Street, we can clearly see the follow through effects across all sectors on the ASX," said Glenn Yin, head of research and analysis at AETOS Capital Group.
In Sydney, financials .AXFJ led for a third straight session, ending the day 0.5% higher at a record-high close.
Miners .AXMM added 1.2% as iron ore prices climbed on hopes that top consumer China will introduce more stimulus at its upcoming key meeting.
BHP (BHP) , Rio Tinto (RIO) and Fortescue (FMG) gained between 0.2% and 1.9%.
Energy stocks .AXEJ added 1.1% on rising crude prices, while gold stocks .AXGD extended gains to an eighth session, climbing 2.2%.
The U.S. inflation data is key for the market to gauge whether the Federal Reserve will start rate cuts in September.
Global central banks, including Australia's, take cues from the Fed.
New Zealand's benchmark S&P/NZX 50 index (nz50) rose 1% to more than a three-month high, in its third straight session of gains.
- Forums
- ASX - By Stock
- XFJ
- News: XFJ Australian shares end near record high; US inflation data on tap
News: XFJ Australian shares end near record high; US inflation data on tap
Featured News
Add XFJ (ASX) to my watchlist
|
|||||
Last
7,881.5 |
Change
54.900(0.70%) |
Mkt cap ! n/a |
Open | High | Low |
7,826.6 | 7,905.5 | 7,826.6 |
Featured News
XFJ (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online